News
This was the stock's third consecutive day of gains.
Aurora Cannabis Inc. closed 36.67% below its 52-week high of $7.20, which the company achieved on August 15th.
Aurora Cannabis sees record Q4-2025 revenues driven by international sales, but low profits and weak 2026 outlook keep stock under pressure.
Canadian LPs offer better balance sheets and global potential vs. U.S. MSOs in cannabis investing. Find out why fundamentals ...
Aurora Cannabis shares tumbled Wednesday as the Canadian cannabis operator said it expects “temporary declines” in its international markets, which include the U.S. ...
Researchers say the health-care system needs to be more aware of cannabis hyperemesis syndrome, a condition characterized by ...
Aurora Cannabis Q4 sales rose 34% to $63.07 million, led by medical cannabis and plant propagation, despite missing earnings estimates.
Aurora Cannabis Inc (TSX:ACB) is set to release its Q4 2025 earnings on June 18, 2025. The consensus estimate for Q4 2025 revenue is $88.82 million, and the earnings are expected to come in at $0.11 ...
Aurora CEO says medical cannabis is profitable and growing—even if investors aren't seeing it yet. Here's what's driving the strategy.
Aurora Cannabis (ACB) announced that it has become aware of “a second instance of misinformation” posted on news website Investing.com. On June 18, Aurora advised the market that an article ...
-Aurora Cannabis Inc., a leading Canada- based global medical cannabis company, today announced its financial and operational results for the fourth quarter and fiscal year 2025 periods ending ...
Aurora Cannabis Inc. (NASDAQ:ACB) Q4 2025 Earnings Call Transcript June 18, 2025 Aurora Cannabis Inc. misses on earnings expectations. Reported EPS is $0.07 EPS, expectations were $0.11.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results